p63 expression in sclerosing mucoepidermoid carcinomas with eosinophilia arising in the thyroid
Authors:
- 1 May 2004
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 17 (5) , 526-529
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- p63 Expression in Solid Cell Nests of the Thyroid: Further Evidence for a Stem Cell OriginLaboratory Investigation, 2003
- p63 in Laryngeal Squamous Cell Carcinoma: Evidence for a Role of TA-p63 Down-Regulation in Tumorigenesis and Lack of Prognostic Implications of p63 ImmunoreactivityLaboratory Investigation, 2002
- Differential expression of p63 isoforms in normal tissues and neoplastic cellsThe Journal of Pathology, 2002
- Taking Advantage of Basic Research: p63 Is a Reliable Myoepithelial and Stem Cell MarkerAdvances in Anatomic Pathology, 2002
- Primary Mucoepidermoid Carcinoma and Sclerosing Mucoepidermoid Carcinoma with Eosinophilia of the Thyroid Gland: A Report of Nine CasesLaboratory Investigation, 2000
- Association of p63 with Proliferative Potential in Normal and Neoplastic Human KeratinocytesJournal of Investigative Dermatology, 1999
- Heterozygous Germline Mutations in the p53 Homolog p63 Are the Cause of EEC SyndromeCell, 1999
- p63 is essential for regenerative proliferation in limb, craniofacial and epithelial developmentNature, 1999
- p63, a p53 Homolog at 3q27–29, Encodes Multiple Products with Transactivating, Death-Inducing, and Dominant-Negative ActivitiesMolecular Cell, 1998
- Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: Report of two patients, one with distant metastasis, and review of the literatureHuman Pathology, 1997